Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 20, 2021
Ursolic acid does not change the cytokine levels following resistance training in healthy men: A pilot balanced, double-blind and placebo-controlled clinical trialPatrícia Cristina Barreto Lobo, Gustavo Duarte Pimentel
The Canadian Journal of Cardiology|November 19, 2025
Thriving Long Term After Heart TransplantationFeras Alkhalaileh, Gustavo Duarte, David A Baran
Muscles (Basel, Switzerland)|June 25, 2026
Correlation Between Hemoglobin Levels with Muscle Function and the Risk of Sarcopenia in Patients with Cancer of the Digestive System: A Cross-Sectional StudyElisa Silva Correia, Jéssika Martins Siqueira, Gustavo Duarte Pimentel
The American Journal of Cardiology|August 3, 2023
Temporal Changes in Racial and Ethnic Disparities in the Utilization of Left Atrial Appendage Occlusion in the United StatesJose Lopez, Gustavo Duarte, Rosario A Colombo, et al.
Einstein (Sao Paulo, Brazil)|January 12, 2017
Sarcopenia and chemotherapy-mediated toxicityMaria Cecília Monteiro Dela Vega, Alessandro Laviano, Gustavo Duarte Pimentel
Current Cardiology Reports|November 17, 2023
Achieving Health Equity in the Care of Patients with Heart FailureJose L Lopez, Gustavo Duarte, Christy N Taylor, et al.
Arzneimittel-Forschung|August 18, 2010
Comparative bioavailability of betahistine tablet formulations administered in healthy subjectsLigia Val, Lu Shi Chen, Gustavo Duarte Mendes, et al.
Environmental Science and Pollution Research International|October 7, 2024
Phytohormonal balance and differential gene expression in chronically irradiated Scots pine populations from the chernobyl affected zoneSofia Bitarishvili, Ekaterina Shesterikova, Alyona Smirnova, et al.
Clinical Nutrition Research|May 2, 2018
Low Handgrip Strength Is Not Associated with Type 2 Diabetes Mellitus and Hyperglycemia: a Population-Based StudyBruna M Giglio, João F Mota, Benjamin T Wall, et al.
Case Reports in Oncology|June 6, 2018
Second-Line Treatment of HER2-Positive Salivary Gland Tumor: Ado-Trastuzumab Emtansine (T-DM1) after Progression on TrastuzumabTatiana Strava Corrêa, Gustavo Duarte Ramos Matos, Marcos Segura, et al.
Pageof 9